Cargando…

MRI-based delta-radiomic features for prediction of local control in liver lesions treated with stereotactic body radiation therapy

Real-time magnetic resonance image guided stereotactic ablative radiotherapy (MRgSBRT) is used to treat abdominal tumors. Longitudinal data is generated from daily setup images. Our study aimed to identify delta radiomic texture features extracted from these images to predict for local control in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Will H., Simpson, Garrett N., Dogan, Nesrin, Spieler, Benjamin, Portelance, Lorraine, Yang, Fei, Ford, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633752/
https://www.ncbi.nlm.nih.gov/pubmed/36329116
http://dx.doi.org/10.1038/s41598-022-22826-5
_version_ 1784824307631783936
author Jin, Will H.
Simpson, Garrett N.
Dogan, Nesrin
Spieler, Benjamin
Portelance, Lorraine
Yang, Fei
Ford, John C.
author_facet Jin, Will H.
Simpson, Garrett N.
Dogan, Nesrin
Spieler, Benjamin
Portelance, Lorraine
Yang, Fei
Ford, John C.
author_sort Jin, Will H.
collection PubMed
description Real-time magnetic resonance image guided stereotactic ablative radiotherapy (MRgSBRT) is used to treat abdominal tumors. Longitudinal data is generated from daily setup images. Our study aimed to identify delta radiomic texture features extracted from these images to predict for local control in patients with liver tumors treated with MRgSBRT. Retrospective analysis of an IRB-approved database identified patients treated with MRgSBRT for primary liver and secondary metastasis histologies. Daily low field strength (0.35 T) images were retrieved, and the gross tumor volume was identified on each image. Next, images’ gray levels were equalized, and 39 s-order texture features were extracted. Delta-radiomics were calculated as the difference between feature values on the initial scan and after delivered biological effective doses (BED, α/β = 10) of 20 Gy and 40 Gy. Then, features were ranked by the Gini Index during training of a random forest model. Finally, the area under the receiver operating characteristic curve (AUC) was estimated using a bootstrapped logistic regression with the top two features. We identified 22 patients for analysis. The median dose delivered was 50 Gy in 5 fractions. The top two features identified after delivery of BED 20 Gy were gray level co-occurrence matrix features energy and gray level size zone matrix based large zone emphasis. The model generated an AUC = 0.9011 (0.752–1.0) during bootstrapped logistic regression. The same two features were selected after delivery of a BED 40 Gy, with an AUC = 0.716 (0.600–0.786). Delta-radiomic features after a single fraction of SBRT predicted local control in this exploratory cohort. If confirmed in larger studies, these features may identify patients with radioresistant disease and provide an opportunity for physicians to alter management much sooner than standard restaging after 3 months. Expansion of the patient database is warranted for further analysis of delta-radiomic features.
format Online
Article
Text
id pubmed-9633752
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96337522022-11-05 MRI-based delta-radiomic features for prediction of local control in liver lesions treated with stereotactic body radiation therapy Jin, Will H. Simpson, Garrett N. Dogan, Nesrin Spieler, Benjamin Portelance, Lorraine Yang, Fei Ford, John C. Sci Rep Article Real-time magnetic resonance image guided stereotactic ablative radiotherapy (MRgSBRT) is used to treat abdominal tumors. Longitudinal data is generated from daily setup images. Our study aimed to identify delta radiomic texture features extracted from these images to predict for local control in patients with liver tumors treated with MRgSBRT. Retrospective analysis of an IRB-approved database identified patients treated with MRgSBRT for primary liver and secondary metastasis histologies. Daily low field strength (0.35 T) images were retrieved, and the gross tumor volume was identified on each image. Next, images’ gray levels were equalized, and 39 s-order texture features were extracted. Delta-radiomics were calculated as the difference between feature values on the initial scan and after delivered biological effective doses (BED, α/β = 10) of 20 Gy and 40 Gy. Then, features were ranked by the Gini Index during training of a random forest model. Finally, the area under the receiver operating characteristic curve (AUC) was estimated using a bootstrapped logistic regression with the top two features. We identified 22 patients for analysis. The median dose delivered was 50 Gy in 5 fractions. The top two features identified after delivery of BED 20 Gy were gray level co-occurrence matrix features energy and gray level size zone matrix based large zone emphasis. The model generated an AUC = 0.9011 (0.752–1.0) during bootstrapped logistic regression. The same two features were selected after delivery of a BED 40 Gy, with an AUC = 0.716 (0.600–0.786). Delta-radiomic features after a single fraction of SBRT predicted local control in this exploratory cohort. If confirmed in larger studies, these features may identify patients with radioresistant disease and provide an opportunity for physicians to alter management much sooner than standard restaging after 3 months. Expansion of the patient database is warranted for further analysis of delta-radiomic features. Nature Publishing Group UK 2022-11-03 /pmc/articles/PMC9633752/ /pubmed/36329116 http://dx.doi.org/10.1038/s41598-022-22826-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Jin, Will H.
Simpson, Garrett N.
Dogan, Nesrin
Spieler, Benjamin
Portelance, Lorraine
Yang, Fei
Ford, John C.
MRI-based delta-radiomic features for prediction of local control in liver lesions treated with stereotactic body radiation therapy
title MRI-based delta-radiomic features for prediction of local control in liver lesions treated with stereotactic body radiation therapy
title_full MRI-based delta-radiomic features for prediction of local control in liver lesions treated with stereotactic body radiation therapy
title_fullStr MRI-based delta-radiomic features for prediction of local control in liver lesions treated with stereotactic body radiation therapy
title_full_unstemmed MRI-based delta-radiomic features for prediction of local control in liver lesions treated with stereotactic body radiation therapy
title_short MRI-based delta-radiomic features for prediction of local control in liver lesions treated with stereotactic body radiation therapy
title_sort mri-based delta-radiomic features for prediction of local control in liver lesions treated with stereotactic body radiation therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633752/
https://www.ncbi.nlm.nih.gov/pubmed/36329116
http://dx.doi.org/10.1038/s41598-022-22826-5
work_keys_str_mv AT jinwillh mribaseddeltaradiomicfeaturesforpredictionoflocalcontrolinliverlesionstreatedwithstereotacticbodyradiationtherapy
AT simpsongarrettn mribaseddeltaradiomicfeaturesforpredictionoflocalcontrolinliverlesionstreatedwithstereotacticbodyradiationtherapy
AT dogannesrin mribaseddeltaradiomicfeaturesforpredictionoflocalcontrolinliverlesionstreatedwithstereotacticbodyradiationtherapy
AT spielerbenjamin mribaseddeltaradiomicfeaturesforpredictionoflocalcontrolinliverlesionstreatedwithstereotacticbodyradiationtherapy
AT portelancelorraine mribaseddeltaradiomicfeaturesforpredictionoflocalcontrolinliverlesionstreatedwithstereotacticbodyradiationtherapy
AT yangfei mribaseddeltaradiomicfeaturesforpredictionoflocalcontrolinliverlesionstreatedwithstereotacticbodyradiationtherapy
AT fordjohnc mribaseddeltaradiomicfeaturesforpredictionoflocalcontrolinliverlesionstreatedwithstereotacticbodyradiationtherapy